Gujarat Kidney IPO Lists Flat: Long-Term Opportunity Amid Healthcare Boom?

• Gujarat Kidney and Super Speciality IPO subscribed 5.21 times, expected to list flat on December 30.
• Grey Market Premium (GMP) indicates a flat listing for the Rs 251-crore IPO.
• India's hospital industry is projected to grow significantly, reaching Rs 8,200 billion by FY2026, supported by government initiatives.
• Expert Ravi Singh sees Gujarat Kidney well-positioned to benefit from rising healthcare demand and recommends it as a potential long-term investment.
• IPO proceeds will fund acquisitions, a new hospital in Vadodara, robotics equipment, debt repayment, and inorganic growth.

Why It Matters: Gujarat Kidney IPO lists flat, but experts see long-term potential in India's growing healthcare sector.